Skip to main content
رجوع
HBMHF logo

HBM Holdings Limited

جودة البيانات: 100%
ذروة بيع
HBMHF
OTC Healthcare Biotechnology
KWD 1.56
KWD 0.00 (0.00%)
القيمة السوقية: 1.30B
نطاق اليوم
KWD 1.56 KWD 2.52
نطاق 52 أسبوعًا
KWD 0.56 KWD 2.54
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 2.08 / KWD 2.00
الإغلاق السابق
KWD 1.56

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 469.2 0.3
P/B 10.5 2.9
ROE % 2.3 3.7
Net Margin % 7.3 3.8
Rev Growth 5Y % 28.2 10.0
D/E 0.5 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 0.000
KWD 0.000 – KWD 0.000
200 M 0
FY2028 KWD 0.000
KWD 0.000 – KWD 0.000
190 M 0
FY2027 KWD 0.071
KWD 0.064 – KWD 0.077
210 M 1

النقاط الرئيسية

Revenue grew 28.19% annually over 5 years — strong growth
Earnings declined -87.81% over the past year
ROE of 2.27% is below average
Debt/Equity of 0.49 — conservative balance sheet
Generating 30.44M in free cash flow
P/E of 469.21 — premium valuation

النمو

Revenue Growth (5Y)
28.19%
Revenue (1Y)-57.43%
Earnings (1Y)-87.81%
FCF Growth (3Y)N/A

الجودة

Return on Equity
2.27%
ROIC-0.88%
Net Margin7.29%
Op. Margin-5.73%

الأمان

Debt / Equity
0.49
Current Ratio2.82
Interest Coverage-0.62

التقييم

P/E Ratio
469.21
P/B Ratio10.47
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -57.43% Revenue Growth (3Y) -3.31%
Earnings Growth (1Y) -87.81% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 28.19% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 38.10M Net Income (TTM) 2.78M
ROE 2.27% ROA 1.29%
Gross Margin 88.23% Operating Margin -5.73%
Net Margin 7.29% Free Cash Flow (TTM) 30.44M
ROIC -0.88% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.49 Current Ratio 2.82
Interest Coverage -0.62 Dividend Yield 0.00%
Valuation
P/E Ratio 469.21 P/B Ratio 10.47
P/S Ratio 34.21 PEG Ratio -0.58
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.30B Enterprise Value 1.20B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 38.10M 89.50M 40.76M 4.29M 14.11M
Net Income 2.78M 22.80M -137.55M -137.32M -296.48M
EPS (Diluted) 0.00 0.03 -0.19 -0.19 -0.39
Gross Profit 33.61M 87.47M 32.57M -2.63M 8.43M
Operating Income -2.19M 21.83M -122.18M -142.53M -81.32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 215.01M 228.48M 231.92M 282.28M 388.74M
Total Liabilities 90.96M 108.85M 139.50M 59.43M 27.73M
Shareholders' Equity 124.45M 119.99M 92.74M 223.13M 361.19M
Total Debt 61.34M 66.01M 90.85M 19.47M 1.73M
Cash & Equivalents 166.82M 140.32M 162.22M 56.29M 256.79M
Current Assets 196.10M 210.18M 208.83M 240.80M 369.30M
Current Liabilities 69.43M 64.13M 74.98M 41.04M 25.55M